Group One Trading, L.P. Eli Lilly & CO Transaction History

Group One Trading, L.P.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 10, 2021	SELL	$130.46 - $172.63 $2.12 Million - $2.81 Million	-16,285 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$146.22 - $169.13 $1.86 Million - $2.16 Million	-12,752 Reduced 43.92%	16,285 $2.41 Million
Q2 2020 Aug 13, 2020	BUY	$136.42 - $164.18 $3.96 Million - $4.77 Million	29,037 New	29,037 $4.77 Million
Q1 2020 May 13, 2020	SELL	$119.05 - $147.35 $1.05 Million - $1.3 Million	-8,806 Closed	0 $0
Q4 2019 Feb 10, 2020	SELL	$106.92 - $132.43 $202,506 - $250,822	-1,894 Reduced 17.7%	8,806 $1.16 Million
Q3 2019 Nov 12, 2019	BUY	$106.79 - $116.16 $1.14 Million - $1.24 Million	10,700 New	10,700 $1.2 Million
Q2 2018 Aug 14, 2018	SELL	$75.7 - $86.88 $1.3 Million - $1.49 Million	-17,178 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$74.21 - $87.6 $1.27 Million - $1.5 Million	17,178 New	17,178 $1.33 Million

4,010

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.